Biomedical Engineering Reference
In-Depth Information
61. Luo, H.,
et al.
, Liposomal honokiol, a promising agent for treatment of cispl-
atin-resistant human ovarian cancer.
J Cancer Res Clin Oncol
, 2008. 134(9):
p. 937-45.
62. Banciu, M.,
et al.
, Antitumor activity and tumor localization of liposomal
glucocorticoids in B16 melanoma-bearing mice.
J Control Release
, 2008.
127(2): p. 131-6.
63. Zolnik, B.S.,
et al.
, Rapid distribution of liposomal short-chain ceramide in
vitro and in vivo.
Drug Metab Dispos
, 2008. 36(8): p. 1709-15.
64. Caraglia, M.,
et al.
, Stealth liposomes encapsulating zoledronic acid: a new
opportunity to treat neuropathic pain.
Mol Pharm
, 2013. 10(3): p. 1111-8.
65. Gaspar, M.M.,
et al.
, Enzymosomes with surface-exposed superoxide dis-
mutase: in vivo behaviour and therapeutic activity in a model of adjuvant
arthritis.
J Control Release
, 2007. 117(2): p. 186-95.
66. Ishii, T.,
et al.
, Amelioration of cerebral ischemia-reperfusion injury based
on liposomal drug delivery system with asialo-erythropoietin.
J Control
Release
, 2012. 160(1): p. 81-7.
67. Kawaguchi, A.T.,
et al.
, Liposome-encapsulated hemoglobin ameliorates
ischemic stroke in nonhuman primates: an acute study.
J Pharmacol Exp
h er
, 2010. 332(2): p. 429-36.
68. Verma, D.D.,
et al.
, Protective ef ect of coenzyme Q10-loaded liposomes on
the myocardium in rabbits with an acute experimental myocardial infarc-
tion.
Pharm Res
, 2007. 24(11): p. 2131-7.
69. Xing, C.,
et al.
, Delivering minocycline into brain endothelial cells with lipo-
some-based technology.
J Cereb Blood Flow Metab
, 2012. 32(6): p. 983-8.
70. Linker, R.A.,
et al.
, Liposomal glucocorticosteroids in treatment of chronic
autoimmune demyelination: long-term protective ef ects and enhanced ei cacy
of methylprednisolone formulations.
Exp Neurol
, 2008. 211(2): p. 397-406.
71. Pan, J.,
et al.
, Enhanced ei cacy of recombinant FVIII in noncovalent com-
plex with PEGylated liposome in hemophilia A mice.
Blood
, 2009. 114(13):
p. 2802-11.
72. Stark, B.,
et al.
, Liposomal vasoactive intestinal peptide for lung application:
protection from proteolytic degradation.
Eur J Pharm Biopharm
, 2008. 70(1):
p. 153-64.
73. van Rooy, I.,
et al.
, Preparation and characterization of liposomal formula-
tions of neurotensin-degrading enzyme inhibitors.
Int J Pharm
, 2011. 416(2):
p. 448-52.
74. Garcia, L.,
et al.
, Serum-resistant lipopolyplexes for gene delivery to liver
tumour cells.
Eur J Pharm Biopharm
, 2007. 67(1): p. 58-66.
75. Ho, E.A.,
et al.
, Characterization of long-circulating cationic nanoparticle
formulations consisting of a two-stage PEGylation step for the delivery of
siRNA in a breast cancer tumor model.
J Pharm Sci
, 2013. 102(1): p. 227-36.
76. Komano, Y.,
et al.
, Arthritic joint-targeting small interfering RNA-
encapsulated liposome: implication for treatment strategy for rheumatoid
arthritis.
J Pharmacol Exp h er
, 2012. 340(1): p. 109-13.
